AI assistant
Barclays PLC Major Shareholding Notification 2021
5250_rns_2021-01-28_920ba89d-377f-45b0-829d-106157c33e6d.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 26 January 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
| (1) | Relevant securities | ||||
| 2,380,665 | 1.85% | 603,813 | 0.47% | ||
| (2) | Derivatives (other than options): | ||||
| 273,127 | 0.21% | 445,393 | 0.35% | ||
| (3) | Options and agreements to | ||||
| purchase/sell: | 6,000 | 0.00% | 6,000 | 0.00% | |
| TOTAL: | |||||
| 2,659,792 | 2.06% | 1,055,206 | 0.82% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
| Class of relevant security: | Long | Short | ||||
| Number | (%) | Number | (%) | |||
| (1) Relevant securities | ||||||
| (2) Derivatives (other than options) | ||||||
| (3) Options and agreements to purchase/sell | ||||||
| Total | ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 3 | 209.1900 USD |
| Purchase | 12 | 209.8975 USD |
| Purchase | 25 | 210.2000 USD |
| Purchase | 35 | 210.1874 USD |
| Purchase | 75 | 210.2197 USD |
| Purchase | 84 | 210.1166 USD |
| Purchase | 90 | 210.3200 USD |
| Purchase | 95 | 210.6822 USD |
| Purchase | 100 | 210.9600 USD |
| Purchase | 100 | 207.9800 USD |
| Purchase | 120 | 208.7100 USD |
| Purchase | 125 | 209.8577 USD |
| Purchase | 500 | 209.9278 USD |
| Purchase | 542 | 210.2352 USD |
| Purchase | 700 | 210.4428 USD |
| Purchase | 929 | 209.9338 USD |
| Purchase | 3,285 | 210.3202 USD |
| Purchase | 11,699 | 209.7097 USD |
| Purchase | 24,511 | 210.1383 USD |
| Purchase | 25,603 | 210.2200 USD |
| Purchase | 51,547 | 209.6694 USD |
| Sale | 3 | 209.1900 USD |
| Sale | 5 | 209.9850 USD |
| Sale | 17 | 210.3200 USD |
| Sale | 60 | 208.7100 USD |
| Sale | 60 | 208.7200 USD |
| Sale | 100 | 207.9800 USD |
| Sale | 100 | 209.2200 USD |
| Sale | 101 | 209.6539 USD |
| Sale | 200 | 210.5600 USD |
| Sale | 238 | 210.6729 USD |
| Sale | 264 | 210.0515 USD |
| Sale | 265 | 208.8234 USD |
| Sale | 537 | 210.3496 USD |
| Sale | 542 | 210.2352 USD |
| Sale | 700 | 210.4428 USD |
| Sale | 800 | 209.2701 USD |
| Sale | 925 | 209.4664 USD |
| Sale | 929 | 209.9338 USD |
| Sale | 1,117 | 209.5882 USD |
| Sale | 1,633 | 209.9275 USD |
| Sale | 1,672 | 209.6342 USD |
| Sale | 2,902 | 209.5807 USD |
| Sale | 2,984 | 209.8739 USD |
| Sale | 3,033 | 210.3419 USD |
| Sale | 3,070 | 210.1075 USD |
| Sale | 3,558 | 209.8851 USD |
| Sale | 4,071 | 209.7242 USD |
| Sale | 10,313 | 209.6086 USD |
| Sale | 10,577 | 209.7224 USD |
| Sale | 11,367 | 209.7868 USD |
| Sale | 14,428 | 209.5551 USD |
| Sale | 18,006 | 210.2199 USD |
| Sale | 25,580 | 210.2200 USD |
(b) Derivatives transactions (other than options transactions)
| Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
| Product name, e.g. call option |
Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
(ii) Exercising
| Product name, e.g. call option |
Number of securities | Exercise price per unit (Note 5) |
(d) Other dealings (including transactions in respect of new securities) (Note 4)
| Nature of transaction (Note 8) |
Details | Price per unit (if applicable) (Note 5) |
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 28 Jan 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210128005452/en/
BARCLAYS PLC